BESTSELLER

China Companion Animal Health Market - Growth, Trends, and Forecast (2019 - 2024)

The China Companion Animal Health Market is segmented by Products and Animal Type (Dogs and Cats, Horses, and Other Companion Animals).

Market Snapshot

Picture 1
Study Period:

2016-2024

Base Year:

2018

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

China Companion Animal Health Market

  • The Chinese companion health market is growing, due to the factors, like the rising popularity of pet ownership in China and the introduction of healthcare innovations converging with different therapeutic indications.
  • According to the National Bureau of Statistics of China, it has been estimated that China is the third-largest country, in terms of dog ownership, a total of 27.4 million pet dogs, standing behind the United States and Brazil, with 55.3 million and 35.7 million dogs, respectively. China also stands second in the ownership of pet cats (58.1 million).
  • With the increase in the number of companion animals, owners are becoming increasingly aware of their pet’s health and nutrition, and are also seeking veterinary services. This, in turn, is creating a growing demand for diversified forms of companion animal healthcare products.

Scope of the Report

Companion animals serve humans by providing them company, as well as by guarding their houses and offices. Nowadays, the various types of health diseases developed in animals have increased the demand for vaccines and diagnostic tests. This surge in the demand is because of the need to treat and cure the variety of diseases associated with the health of cats and dogs.

By Products
Therapeutics
Vaccines
Parasiticides
Anti-Infectives
Medicinal Feed Additives
Other Therapeutics
Diagnostics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Other Diagnostics
By Animal Type
Dogs and Cats
Horses
Other Companion Animals

Report scope can be customized per your requirements. Click here.

Key Market Trends

Vaccines Contributed the Largest Share, in Terms of Revenues, in the Therapeutics Segment

The three major types of vaccines available for companion animals are inactivated (killed) vaccines (which contain bacteria and virus that have been grown in cultures and then killed by heating or chemical treatments), live attenuated vaccines (which contain live viruses or bacteria that have been severely weakened), and subunit vaccines (which contain viral or bacterial antigens that can trigger an immune response). In 2017, more than 3,500 cats and dogs were cured from various diseases in China through animal welfare programs, funded by the Animals Asia Foundation. The animals were cured and vaccinated efficiently, thus protecting their health and saving their life.

Picture 2

To understand key trends, Download Sample Report

Competitive Landscape

Leading global companies are partnering with the Chinese companies for their distribution in the country. For instance, Meili Omni-Honesty is a joint venture between Boehringer Ingelheim, a leading global pharmaceutical company and the world's second-largest animal health company, Beijing KangMu Omni-Honesty Animal Health Products Co. Ltd. Key market players in the market include Bayer AG, China Animal Husbandry Co. Ltd, Dachang, Elanco Animal Health, Merck & Co., Vetoquinol SA, Virbac, and Zoetis Inc., among others.

Major Players

  1. Bayer AG
  2. Elanco Animal Health
  3. Merck & Co.
  4. Virbac
  5. Zoetis Inc.

* Complete list of players covered available in the table of contents below

China Companion

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Pet Adoption, Mostly by Nuclear Families

      2. 4.2.2 Increasing in Initiatives by the Governments and Animal Welfare Associations

      3. 4.2.3 Advanced Technology in Animal Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Use of Counterfeit Medicines

      2. 4.3.2 Increasing Costs of Animal Testing and Veterinary Care

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Products

      1. 5.1.1 Therapeutics

        1. 5.1.1.1 Vaccines

        2. 5.1.1.2 Parasiticides

        3. 5.1.1.3 Anti-Infectives

        4. 5.1.1.4 Medicinal Feed Additives

        5. 5.1.1.5 Other Therapeutics

      2. 5.1.2 Diagnostics

        1. 5.1.2.1 Immunodiagnostic Tests

        2. 5.1.2.2 Molecular Diagnostics

        3. 5.1.2.3 Diagnostic Imaging

        4. 5.1.2.4 Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Other Companion Animals

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bayer AG

      2. 6.1.2 China Animal Husbandry Co. Ltd

      3. 6.1.3 Dachang

      4. 6.1.4 Elanco Animal Health

      5. 6.1.5 Merck & Co.

      6. 6.1.6 Vetoquinol SA

      7. 6.1.7 Virbac

      8. 6.1.8 Zoetis Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information